CELLSCRIPT, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for CELLSCRIPT, LLC.The latest application filed is for "making and using in vitro-synthesized ssrna for introducing into mammalian cells to induce a biological or biochemical effect".

Company Profile

7.15.12

CELLSCRIPT, LLC - Madison WI US
CellScript, LLC. - Madison WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT App 20220257795 - Meis; Judith ; et al.	2022-08-18
Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect Grant 11,135,314 - Meis , et al. October 5, 2	2021-10-05
Inhibition Of Innate Immune Response App 20210079346 - Chin; Cynthia ; et al.	2021-03-18
Treatment Of Infections And Immune Dysregulation In Patients With Primary Immune Deficiencies Using Mrna-corrected Autologous Granulocytes, Lymphocytes And/or Natural Killer Cells App 20210000926 - De Ravin; Suk See ; et al.	2021-01-07
Inhibition of innate immune response Grant 10,793,831 - Chin , et al. October 6, 2	2020-10-06
MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT App 20190321490 - Meis; Judith ; et al.	2019-10-24
Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect Grant 10,201,620 - Meis , et al. Feb	2019-02-12
Inhibition Of Innate Immune Response App 20180312806 - Chin; Cynthia ; et al.	2018-11-01
Inhibition of innate immune response Grant 9,862,926 - Chin , et al. January 9, 2	2018-01-09
Kits and methods for generating 5' capped RNA Grant 9,115,380 - Jendrisak , et al. August 25, 2	2015-08-25
Kits And Methods For Generating 5' Capped Rna App 20150191760 - Jendrisak; Jerome ; et al.	2015-07-09
RNA polyphosphatase compositions, kits, and uses thereof Grant 9,017,970 - Jendrisak , et al. April 28, 2	2015-04-28
Kits and methods for generating 5' capped RNA Grant 9,005,930 - Jendrisak , et al. April 14, 2	2015-04-14
Kits And Methods For Generating 5' Capped Rna App 20140363876 - Jendrisak; Jerome ; et al.	2014-12-11
MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT App 20140328825 - Meis; Judith ; et al.	2014-11-06
Compositions And Methods For Reprogramming Eukaryotic Cells App 20140315988 - Dahl; Gary ; et al.	2014-10-23
Kits and methods for generating 5' capped RNA Grant 8,846,348 - Jendrisak , et al. September 30, 2	2014-09-30
Compositions and methods for reprogramming eukaryotic cells Grant 8,808,982 - Dahl , et al. August 19, 2	2014-08-19
Inhibition Of Innate Immune Response App 20140227300 - Chin; Cynthia ; et al.	2014-08-14
Kits And Methods For Generating 5' Capped Rna App 20140221248 - Jendrisak; Jerome ; et al.	2014-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.